Fig. 3
(Short title) Daily urinary prostaglandin and enzyme excretion (activity). (Detailed legend) Daily urinary prostanoids excretion [PGE2 (a), TxB2 (b) and 6-ketoPGF1α (c)], daily proteinuria (d), gamma-Glutamyl transpeptidase (e) and N-acetyl-beta-D-glucosaminidase, NAG (f) urinary activities at baseline (white columns) and after administration of oral furosemide (2 mg kg−1 twice-daily, couloured columns) with either placebo (Plac.), robenacoxib 1 to 2 mg kg−1 once- Rob(1/d) or twice-daily Rob(2/d), or ketoprofen once-daily (Keto, 1 mg kg−1). Data are presented as mean (SD) for seven healthy cats enrolled in the crossover study. Significant change from baseline are notified as * P < 0.05 and *** P < 0.001. Significant differences between treatment groups are notified as # P < 0.05